7 | Biomarkers (Surrogate Marker)IBA
05/2022
-
01/2018 |
4 | Pharmaceutical PreparationsIBA
03/2022
-
04/2005 |
4 | Indicators and Reagents (Reagents)IBA
01/2019
-
12/2007 |
3 | CateninsIBA
05/2022
-
01/2017 |
3 | Estrogens (Estrogen)FDA Link
01/2022
-
01/2017 |
3 | Interleukin-6 (Interleukin 6)IBA
01/2022
-
04/2005 |
3 | Biological ProductsIBA
01/2021
-
09/2014 |
3 | Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2018
-
04/2005 |
3 | Proteins (Proteins, Gene)FDA Link
10/2016
-
01/2013 |
2 | Cisplatin (Platino)FDA LinkGeneric
03/2022
-
01/2017 |
2 | RNA (Ribonucleic Acid)IBA
03/2022
-
10/2014 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
-
02/2003 |
2 | Fibrinogen (Factor I)FDA Link
01/2021
-
01/2019 |
2 | Antineoplastic Agents (Antineoplastics)IBA
01/2021
-
01/2012 |
2 | radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA
02/2018
-
01/2018 |
2 | TabletsIBA
02/2018
-
01/2018 |
2 | Blood Proteins (Serum Proteins)IBA
02/2018
-
01/2018 |
2 | CytokinesIBA
01/2018
-
04/2005 |
2 | Small Interfering RNA (siRNA)IBA
01/2018
-
03/2013 |
2 | HMGB1 Protein (HMG1)IBA
01/2018
-
05/2006 |
2 | Angiotensin IIIBA
01/2018
-
01/2018 |
2 | ChemokinesIBA
01/2018
-
04/2005 |
2 | SteroidsIBA
01/2018
-
06/2017 |
2 | HydrogelsIBA
01/2017
-
01/2012 |
2 | MicroRNAs (MicroRNA)IBA
01/2016
-
02/2015 |
2 | IntegrinsIBA
02/2009
-
07/2006 |
1 | Remifentanil (Ultiva)FDA Link
04/2022 |
1 | Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2022 |
1 | Estrogen ReceptorsIBA
01/2022 |
1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2022 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 |
1 | SynucleinsIBA
11/2021 |
1 | trametinibIBA
10/2021 |
1 | Mitogen-Activated Protein KinasesIBA
10/2021 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2021 |
1 | N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
09/2021 |
1 | Histone Acetyltransferases (Histone Acetyltransferase)IBA
09/2021 |
1 | Circular RNAIBA
02/2021 |
1 | OrnithineIBA
01/2021 |
1 | Arginine (L-Arginine)FDA Link
01/2021 |
1 | Long Noncoding RNAIBA
01/2021 |
1 | AntibodiesIBA
01/2021 |
1 | Fluorescent Dyes (Fluorescent Probes)IBA
01/2021 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2021 |
1 | Urea (Carbamide)FDA LinkGeneric
01/2021 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2021 |
1 | Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
01/2021 |
1 | CitrullineIBA
01/2021 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 |
1 | Neuroprotective AgentsIBA
11/2020 |
1 | Adenosine A3 ReceptorIBA
11/2020 |
1 | Ketoglutaric Acids (Ketoglutaric Acid)IBA
11/2020 |
1 | Histones (Histone)IBA
11/2020 |
1 | VaccinesIBA
01/2020 |
1 | urinastatin (MR 20)IBA
12/2018 |